APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Nuclear Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Diagnostic Nuclear Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchDiagnostic Nuclear Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Nuclear Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Diagnostic Nuclear Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Nuclear Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Nuclear Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Diagnostic Nuclear Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Diagnostic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diagnostic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diagnostic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Diagnostic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diagnostic Nuclear Drug include Bracco Imaging, Cardinal Health, Curium Pharma, GE Healthcare, Jubilant Pharma, Lantheus, SIEMENS, Dongcheng and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Diagnostic Nuclear Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diagnostic Nuclear Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diagnostic Nuclear Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Diagnostic Nuclear Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Diagnostic Nuclear Drug Segment by Company

Bracco Imaging

Cardinal Health

Curium Pharma

GE Healthcare

Jubilant Pharma

Lantheus

SIEMENS

Dongcheng

Eli Lilly

Novartis

China Isotope & Radiation

Diagnostic Nuclear Drug Segment by Type

Tc-99m

F-18

Other

Diagnostic Nuclear Drug Segment by Application

Oncology

Cardiology

Other

Diagnostic Nuclear Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Nuclear Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Nuclear Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Nuclear Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Diagnostic Nuclear Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diagnostic Nuclear Drug industry.

Chapter 3: Detailed analysis of Diagnostic Nuclear Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Nuclear Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diagnostic Nuclear Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tc-99m Table 3. Key Players of F-18 Table 4. Key Players of Other Table 4. Global Diagnostic Nuclear Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Oncology Table 6. Key Players of Cardiology Table 7. Key Players of Other Table 8. Global Diagnostic Nuclear Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Diagnostic Nuclear Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Diagnostic Nuclear Drug Market Share by Region (2021-2026) Table 11. Global Diagnostic Nuclear Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Diagnostic Nuclear Drug Market Share by Region (2027-2032) Table 13. Diagnostic Nuclear Drug Industry Trends Table 14. Diagnostic Nuclear Drug Industry Drivers Table 15. Diagnostic Nuclear Drug Industry Opportunities and Challenges Table 16. Diagnostic Nuclear Drug Industry Restraints Table 17. Global Diagnostic Nuclear Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Diagnostic Nuclear Drug Revenue Market Share by Company (2021-2026) Table 19. Global Diagnostic Nuclear Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Diagnostic Nuclear Drug Key Company Head Office and Area Served Table 21. Global Diagnostic Nuclear Drug Company, Product Type & Application Table 22. Global Diagnostic Nuclear Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Diagnostic Nuclear Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Diagnostic Nuclear Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Diagnostic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Diagnostic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2021-2026) Table 29. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2027-2032) Table 30. Global Diagnostic Nuclear Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Diagnostic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Diagnostic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2021-2026) Table 34. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2027-2032) Table 35. Bracco Imaging Company Information Table 36. Bracco Imaging Business Overview Table 37. Bracco Imaging Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bracco Imaging Diagnostic Nuclear Drug Product Portfolio Table 39. Bracco Imaging Recent Development Table 40. Cardinal Health Company Information Table 41. Cardinal Health Business Overview Table 42. Cardinal Health Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Cardinal Health Diagnostic Nuclear Drug Product Portfolio Table 44. Cardinal Health Recent Development Table 45. Curium Pharma Company Information Table 46. Curium Pharma Business Overview Table 47. Curium Pharma Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Curium Pharma Diagnostic Nuclear Drug Product Portfolio Table 49. Curium Pharma Recent Development Table 50. GE Healthcare Company Information Table 51. GE Healthcare Business Overview Table 52. GE Healthcare Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. GE Healthcare Diagnostic Nuclear Drug Product Portfolio Table 54. GE Healthcare Recent Development Table 55. Jubilant Pharma Company Information Table 56. Jubilant Pharma Business Overview Table 57. Jubilant Pharma Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Jubilant Pharma Diagnostic Nuclear Drug Product Portfolio Table 59. Jubilant Pharma Recent Development Table 60. Lantheus Company Information Table 61. Lantheus Business Overview Table 62. Lantheus Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Lantheus Diagnostic Nuclear Drug Product Portfolio Table 64. Lantheus Recent Development Table 65. SIEMENS Company Information Table 66. SIEMENS Business Overview Table 67. SIEMENS Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SIEMENS Diagnostic Nuclear Drug Product Portfolio Table 69. SIEMENS Recent Development Table 70. Dongcheng Company Information Table 71. Dongcheng Business Overview Table 72. Dongcheng Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Dongcheng Diagnostic Nuclear Drug Product Portfolio Table 74. Dongcheng Recent Development Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Eli Lilly Diagnostic Nuclear Drug Product Portfolio Table 79. Eli Lilly Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Novartis Diagnostic Nuclear Drug Product Portfolio Table 84. Novartis Recent Development Table 85. China Isotope & Radiation Company Information Table 86. China Isotope & Radiation Business Overview Table 87. China Isotope & Radiation Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. China Isotope & Radiation Diagnostic Nuclear Drug Product Portfolio Table 89. China Isotope & Radiation Recent Development Table 90. North America Diagnostic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Diagnostic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Diagnostic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Diagnostic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Diagnostic Nuclear Drug Market Size by Country (2021-2026) Table 96. North America Diagnostic Nuclear Drug Market Size by Country (2027-2032) Table 97. Europe Diagnostic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Diagnostic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Diagnostic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Diagnostic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Diagnostic Nuclear Drug Market Size by Country (2021-2026) Table 103. Europe Diagnostic Nuclear Drug Market Size by Country (2027-2032) Table 104. China Diagnostic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 105. China Diagnostic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 106. China Diagnostic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 107. China Diagnostic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Diagnostic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Diagnostic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Diagnostic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Diagnostic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Diagnostic Nuclear Drug Market Size by Country (2021-2026) Table 114. Asia Diagnostic Nuclear Drug Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Diagnostic Nuclear Drug Product Image Figure 2. Global Diagnostic Nuclear Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Diagnostic Nuclear Drug Market Share by Type: 2025 VS 2032 Figure 4. Tc-99m Image Figure 5. F-18 Image Figure 6. Other Image Figure 7. Global Diagnostic Nuclear Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Diagnostic Nuclear Drug Market Share by Application: 2025 VS 2032 Figure 9. Oncology Image Figure 10. Cardiology Image Figure 11. Other Image Figure 12. Global Diagnostic Nuclear Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global Diagnostic Nuclear Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Diagnostic Nuclear Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Diagnostic Nuclear Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Diagnostic Nuclear Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Diagnostic Nuclear Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Diagnostic Nuclear Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America Diagnostic Nuclear Drug Market Share by Type (2021-2032) Figure 25. North America Diagnostic Nuclear Drug Market Share by Application (2021-2032) Figure 26. North America Diagnostic Nuclear Drug Market Share by Country (2021-2032) Figure 27. United States Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Diagnostic Nuclear Drug Market Share by Type (2021-2032) Figure 32. Europe Diagnostic Nuclear Drug Market Share by Application (2021-2032) Figure 33. Europe Diagnostic Nuclear Drug Market Share by Country (2021-2032) Figure 34. Germany Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 35. France Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 40. China Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Diagnostic Nuclear Drug Market Share by Type (2021-2032) Figure 42. China Diagnostic Nuclear Drug Market Share by Application (2021-2032) Figure 43. Asia Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia Diagnostic Nuclear Drug Market Share by Type (2021-2032) Figure 45. Asia Diagnostic Nuclear Drug Market Share by Application (2021-2032) Figure 46. Asia Diagnostic Nuclear Drug Market Share by Country (2021-2032) Figure 47. Japan Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 51. India Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Diagnostic Nuclear Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Diagnostic Nuclear Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Diagnostic Nuclear Drug Market Share by Country (2021-2032) Figure 57. Brazil Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile Diagnostic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • F-18
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Cardinal Health
  • Curium Pharma
  • GE Healthcare
  • Jubilant Pharma
  • Lantheus
  • SIEMENS
  • Dongcheng
  • Eli Lilly
  • Novartis
  • China Isotope & Radiation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tc-99m
  5. 1.2.3 F-18
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Oncology
  10. 1.3.3 Cardiology
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Diagnostic Nuclear Drug Growth Trends by Region
  14. 1.5.1 Global Diagnostic Nuclear Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Diagnostic Nuclear Drug Market Size by Region (2021-2026)
  16. 1.5.3 Diagnostic Nuclear Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Diagnostic Nuclear Drug Market Dynamics
  1. 2.1 Diagnostic Nuclear Drug Industry Trends
  2. 2.2 Diagnostic Nuclear Drug Industry Drivers
  3. 2.3 Diagnostic Nuclear Drug Industry Opportunities and Challenges
  4. 2.4 Diagnostic Nuclear Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Diagnostic Nuclear Drug Revenue by Company (2021-2026)
  2. 3.2 Global Diagnostic Nuclear Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Diagnostic Nuclear Drug Key Company Head office and Area Served
  4. 3.4 Global Diagnostic Nuclear Drug Company, Product Type & Application
  5. 3.5 Global Diagnostic Nuclear Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Diagnostic Nuclear Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Diagnostic Nuclear Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Diagnostic Nuclear Drug Tier 1, Tier 2, and Tier 3
4 Diagnostic Nuclear Drug Market by Type
  1. 4.1 Global Diagnostic Nuclear Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Diagnostic Nuclear Drug Market Size by Type (2021-2032)
  3. 4.3 Global Diagnostic Nuclear Drug Market Size Share by Type (2021-2032)
5 Diagnostic Nuclear Drug Market by Application
  1. 5.1 Global Diagnostic Nuclear Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Diagnostic Nuclear Drug Market Size by Application (2021-2032)
  3. 5.3 Global Diagnostic Nuclear Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bracco Imaging
  2. 6.1.1 Bracco Imaging Company Information
  3. 6.1.2 Bracco Imaging Business Overview
  4. 6.1.3 Bracco Imaging Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bracco Imaging Diagnostic Nuclear Drug Product Portfolio
  6. 6.1.5 Bracco Imaging Recent Developments
  7. 6.2 Cardinal Health
  8. 6.2.1 Cardinal Health Company Information
  9. 6.2.2 Cardinal Health Business Overview
  10. 6.2.3 Cardinal Health Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cardinal Health Diagnostic Nuclear Drug Product Portfolio
  12. 6.2.5 Cardinal Health Recent Developments
  13. 6.3 Curium Pharma
  14. 6.3.1 Curium Pharma Company Information
  15. 6.3.2 Curium Pharma Business Overview
  16. 6.3.3 Curium Pharma Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Curium Pharma Diagnostic Nuclear Drug Product Portfolio
  18. 6.3.5 Curium Pharma Recent Developments
  19. 6.4 GE Healthcare
  20. 6.4.1 GE Healthcare Company Information
  21. 6.4.2 GE Healthcare Business Overview
  22. 6.4.3 GE Healthcare Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GE Healthcare Diagnostic Nuclear Drug Product Portfolio
  24. 6.4.5 GE Healthcare Recent Developments
  25. 6.5 Jubilant Pharma
  26. 6.5.1 Jubilant Pharma Company Information
  27. 6.5.2 Jubilant Pharma Business Overview
  28. 6.5.3 Jubilant Pharma Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Jubilant Pharma Diagnostic Nuclear Drug Product Portfolio
  30. 6.5.5 Jubilant Pharma Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lantheus Diagnostic Nuclear Drug Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 SIEMENS
  38. 6.7.1 SIEMENS Company Information
  39. 6.7.2 SIEMENS Business Overview
  40. 6.7.3 SIEMENS Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 SIEMENS Diagnostic Nuclear Drug Product Portfolio
  42. 6.7.5 SIEMENS Recent Developments
  43. 6.8 Dongcheng
  44. 6.8.1 Dongcheng Company Information
  45. 6.8.2 Dongcheng Business Overview
  46. 6.8.3 Dongcheng Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Dongcheng Diagnostic Nuclear Drug Product Portfolio
  48. 6.8.5 Dongcheng Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Eli Lilly Diagnostic Nuclear Drug Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Novartis Diagnostic Nuclear Drug Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 China Isotope & Radiation
  62. 6.11.1 China Isotope & Radiation Company Information
  63. 6.11.2 China Isotope & Radiation Business Overview
  64. 6.11.3 China Isotope & Radiation Diagnostic Nuclear Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 China Isotope & Radiation Diagnostic Nuclear Drug Product Portfolio
  66. 6.11.5 China Isotope & Radiation Recent Developments
7 North America
  1. 7.1 North America Diagnostic Nuclear Drug Market Size (2021-2032)
  2. 7.2 North America Diagnostic Nuclear Drug Market Size by Type
  3. 7.2.1 North America Diagnostic Nuclear Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Diagnostic Nuclear Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Diagnostic Nuclear Drug Market Share by Type (2021-2032)
  6. 7.3 North America Diagnostic Nuclear Drug Market Size by Application
  7. 7.3.1 North America Diagnostic Nuclear Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Diagnostic Nuclear Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Diagnostic Nuclear Drug Market Share by Application (2021-2032)
  10. 7.4 North America Diagnostic Nuclear Drug Market Size by Country
  11. 7.4.1 North America Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Diagnostic Nuclear Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Diagnostic Nuclear Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Diagnostic Nuclear Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Diagnostic Nuclear Drug Market Size (2021-2032)
  2. 8.2 Europe Diagnostic Nuclear Drug Market Size by Type
  3. 8.2.1 Europe Diagnostic Nuclear Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Diagnostic Nuclear Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Diagnostic Nuclear Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Diagnostic Nuclear Drug Market Size by Application
  7. 8.3.1 Europe Diagnostic Nuclear Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Diagnostic Nuclear Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Diagnostic Nuclear Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Diagnostic Nuclear Drug Market Size by Country
  11. 8.4.1 Europe Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Diagnostic Nuclear Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Diagnostic Nuclear Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Diagnostic Nuclear Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Diagnostic Nuclear Drug Market Size (2021-2032)
  2. 9.2 China Diagnostic Nuclear Drug Market Size by Type
  3. 9.2.1 China Diagnostic Nuclear Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Diagnostic Nuclear Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Diagnostic Nuclear Drug Market Share by Type (2021-2032)
  6. 9.3 China Diagnostic Nuclear Drug Market Size by Application
  7. 9.3.1 China Diagnostic Nuclear Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Diagnostic Nuclear Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Diagnostic Nuclear Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Diagnostic Nuclear Drug Market Size (2021-2032)
  2. 10.2 Asia Diagnostic Nuclear Drug Market Size by Type
  3. 10.2.1 Asia Diagnostic Nuclear Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Diagnostic Nuclear Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Diagnostic Nuclear Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Diagnostic Nuclear Drug Market Size by Application
  7. 10.3.1 Asia Diagnostic Nuclear Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Diagnostic Nuclear Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Diagnostic Nuclear Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Diagnostic Nuclear Drug Market Size by Country
  11. 10.4.1 Asia Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Diagnostic Nuclear Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Diagnostic Nuclear Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Diagnostic Nuclear Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Diagnostic Nuclear Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Diagnostic Nuclear Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Diagnostic Nuclear Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Diagnostic Nuclear Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst